Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |